📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Highway Infrastructure Q3 Standalone Net Profit Rises 38% YoY to ₹61.10 Million
Highway Infrastructure Limited reported a robust year-on-year performance for the quarter ended December 31, 2025. Standalone revenue from operations grew 15.6% YoY to ₹1,278.27 million, while standalone net profit increased by 38% to ₹61.10 million. Although Profit Before Tax (PBT) showed a sequential decline from Q2 due to a one-time gain in the previous quarter, the core operational performance remains strong across its Tollway, EPC, and Real Estate segments. The company's consolidated results were slightly lower than standalone due to minor losses in subsidiary entities.
Key Highlights
Standalone revenue from operations increased 15.6% YoY to ₹1,278.27 million from ₹1,105.99 million.
Standalone net profit for Q3 FY26 stood at ₹61.10 million, up from ₹44.28 million in Q3 FY25.
Profit Before Tax (PBT) surged 84.5% YoY to ₹78.38 million compared to ₹42.49 million in the same period last year.
Basic Earnings Per Share (EPS) improved to ₹0.92 from ₹0.77 YoY.
Consolidated net profit for the quarter was ₹58.47 million, reflecting a loss of ₹2.63 million from subsidiary operations.
💼 Action for Investors
Investors should view the strong YoY growth in revenue and net profit as a positive indicator of operational scaling. The stock remains attractive for those seeking exposure to the Indian infrastructure and toll collection sectors, though monitoring subsidiary performance is advised.
HILINFRA Q3 FY26: Order Book Surges 50% to Rs 1,160 Cr; 9M PAT Jumps 121% YoY
Highway Infrastructure Limited (HILINFRA) reported a significant 50% growth in its consolidated order book, reaching Rs 1,160 crore as of January 2026. The company secured its largest-ever tollway collection contract worth Rs 328.8 crore in Andhra Pradesh, bolstering its asset-light business model. For 9M FY26, consolidated PAT surged by 121.5% YoY to Rs 23.1 crore, driven by improved operational efficiencies and higher margins. Management is targeting the completion of Rs 400-450 crore worth of EPC projects over the next two years, providing strong revenue visibility.
Key Highlights
Consolidated order book grew from Rs 775 Cr in Sep'25 to Rs 1,160 Cr in Jan'26, a 50% increase.
Secured the largest single tollway contract in company history worth Rs 328.8 Cr for Kaza Fee Plaza.
9M FY26 standalone PAT witnessed a massive 191.7% YoY growth to Rs 22.9 Cr.
EPC order book expanded by 49.5% since March 2025 to reach Rs 623.6 Cr.
Consolidated EBITDA margins improved significantly to 9.9% in 9M FY26 from 5.8% in the previous year.
💼 Action for Investors
Investors should focus on the company's ability to execute its record order book and maintain the high EBITDA margins achieved in the tollway segment. The strong growth in the EPC pipeline and diversification into 11 states suggest a robust scaling phase.
HILINFRA Q3 PAT Up 34% YoY; Order Book Hits Record ₹1,160 Crore
Highway Infrastructure Limited (HIL) reported a strong Q3 FY26 with PAT growing 34.3% YoY to ₹6.3 crore, despite a 9.6% decline in total income. The company achieved its highest-ever consolidated order book of ₹1,160 crore as of January 2026, representing a 50% growth since September 2025. The Tollway segment was a major driver, with its order book surging 181% to ₹536.5 crore, including a landmark ₹328.8 crore contract in Andhra Pradesh. For 9M FY26, the company showed exceptional performance with PAT rising 121.5% YoY to ₹23.1 crore and EBITDA margins expanding by 413 basis points.
Key Highlights
Consolidated order book reached a record ₹1,160 crore, a 50% increase from ₹775 crore in September 2025.
9M FY26 PAT surged 121.5% YoY to ₹23.1 crore, while Q3 FY26 PAT rose 34.3% YoY to ₹6.3 crore.
EBITDA margins for 9M FY26 improved significantly to 9.9%, up from 5.8% in the previous year.
Secured the largest toll collection order in company history worth ₹328.8 crore for the Kaza Fee Plaza.
EPC order book stands at ₹623.6 crore with a target to complete ₹400–450 crore of projects within two years.
💼 Action for Investors
Investors should view the record order book and significant margin expansion as strong indicators of future growth and operational efficiency. The stock warrants a positive outlook given the high revenue visibility and the company's successful scaling of its asset-light tolling business.
Highway Infrastructure Q3 Net Profit Rises 38% YoY to ₹61.1 Million; Revenue Up 15.6%
Highway Infrastructure Limited reported a standalone revenue of ₹1,278.27 million for Q3 FY26, marking a 15.6% growth compared to ₹1,105.99 million in the same quarter last year. Net profit for the quarter stood at ₹61.10 million, up 38% YoY from ₹44.28 million. Although sequential profit declined from ₹96.02 million, the previous quarter's results were significantly aided by a one-time gain of ₹197.90 million on conversion of stock. The company maintains a steady growth trajectory across its Tollway, EPC, and Real Estate segments.
Key Highlights
Standalone Revenue from Operations increased to ₹1,278.27 million from ₹1,105.99 million YoY.
Net Profit grew to ₹61.10 million compared to ₹44.28 million in the corresponding quarter of the previous year.
Total Income for the nine-month period ended December 2025 reached ₹3,534.06 million.
Operating costs for the quarter rose to ₹1,251.54 million, reflecting increased activity in EPC and infrastructure projects.
Basic EPS for the quarter improved to ₹0.92 from ₹0.77 in the year-ago period.
💼 Action for Investors
Investors should view the YoY growth as a positive indicator of operational scaling, while ignoring the sequential profit dip which was caused by a non-recurring gain in Q2. The company's diversified presence in Tollway and EPC provides a stable revenue base for long-term holders.
Shilpa Medicare Q3 FY26 Results: Consolidated Net Profit Jumps 40% YoY to ₹44.58 Crore
Shilpa Medicare reported a robust performance for Q3 FY26, with consolidated revenue growing 28.3% YoY to ₹409.73 crore. Net profit for the quarter rose significantly by 40.3% YoY to ₹44.58 crore, driven by strong operational execution despite a marginal 1.2% growth on a sequential basis. A major strategic milestone was achieved with the filing of the Rotigotine Transdermal System, the company's first transdermal patch ANDA, with the USFDA. The company also reconstituted its Audit Committee, inducting Mr. Ashraf Allam as an independent director.
Key Highlights
Consolidated Revenue from operations increased to ₹409.73 crore, up 28.3% from ₹319.30 crore in Q3 FY25.
Net Profit attributable to owners grew 40.3% YoY to ₹44.58 crore compared to ₹31.78 crore in the previous year.
Nine-month (9M FY26) consolidated profit reached ₹135.53 crore, more than doubling from ₹63.79 crore in 9M FY25.
Filed the first Transdermal Patch ANDA (Rotigotine) with the USFDA, targeting the complex generics market.
Consolidated EPS for the quarter stood at ₹2.36, up from ₹1.63 in the corresponding quarter of the previous year.
💼 Action for Investors
Investors should take note of the significant YoY profit growth and the strategic entry into the high-entry-barrier transdermal patch segment. The stock remains a positive long-term play as the company transitions toward more complex generic formulations.
Shilpa Medicare Q3 FY26: Adj. PAT Surges 72% YoY to ₹55 Cr; Highest Ever Quarterly Revenue
Shilpa Medicare reported its strongest-ever quarterly performance in Q3 FY26, with revenue growing 28% YoY to ₹411 crore and adjusted PAT jumping 72% to ₹55 crore. The growth was driven by a 50% surge in the Formulations segment and robust traction in Biologics, while EBITDA margins expanded by 200 bps to 28%. For the 9M FY26 period, the company has already surpassed its full-year FY25 PAT, reaching ₹146 crore. Management highlighted significant progress in high-value product launches, including NorUDCA for NAFLD in India and EU approval for the Rotigotine patch.
Key Highlights
Q3 FY26 Revenue grew 28% YoY to ₹411 crore, marking the highest quarterly revenue in the company's history.
Adjusted PAT for the quarter rose 72% YoY to ₹55 crore, while 9M FY26 PAT doubled compared to the full-year FY25 PAT.
EBITDA increased 40% YoY to ₹115 crore with margins improving to 28% from 26% in the previous year.
Formulations segment saw 50% YoY growth, specifically driven by a 107% revenue increase in the EU market.
Net Debt to EBITDA improved to 1.4x from 1.6x in FY25, alongside an improved Adjusted ROCE of 17.1%.
💼 Action for Investors
Investors should note the significant margin expansion and the successful commercialization of the R&D pipeline, particularly in complex generics and biologics. The stock remains attractive for long-term investors as the company transitions toward higher-margin specialty products and improves its capital efficiency.
Shilpa Medicare Q3 Consolidated PAT Rises 40% YoY to ₹44.58 Cr; Revenue Up 28%
Shilpa Medicare reported a robust performance for Q3 FY26, with consolidated revenue growing 28% YoY to ₹410.54 Cr. Consolidated Net Profit surged 40% YoY to ₹44.58 Cr, even after accounting for an exceptional loss of ₹12.86 Cr. For the nine-month period, the company's consolidated PAT more than doubled to ₹135.53 Cr compared to ₹63.78 Cr in the previous year. The board also strengthened its governance by inducting Mr. Ashraf Allam into the Audit Committee.
Key Highlights
Consolidated Revenue from operations increased 28.1% YoY to ₹41,054.10 lakhs in Q3 FY26.
Consolidated Net Profit grew 40.3% YoY to ₹4,458.22 lakhs, showing strong operational efficiency.
Nine-month consolidated PAT reached ₹135.53 Cr, a significant jump from ₹63.78 Cr in the prior year period.
Exceptional items included a ₹12.86 Cr consolidated loss due to impairment provisions in foreign subsidiaries and gratuity liability adjustments.
Consolidated Basic EPS for the quarter improved to ₹2.36 from ₹1.63 in the year-ago period.
💼 Action for Investors
The strong YoY growth in both top-line and bottom-line suggests improving business fundamentals and operational scale. Investors should maintain a positive outlook while monitoring the recurring nature of impairment provisions in foreign subsidiaries.
Shilpa Medicare Q3 FY26 Consolidated Net Profit Rises 40% YoY to ₹44.58 Crore
Shilpa Medicare reported a strong performance for the quarter ended December 31, 2025, with consolidated revenue from operations growing 28.3% YoY to ₹409.73 crore. Consolidated net profit for the quarter stood at ₹44.58 crore, a significant jump from ₹31.78 crore in the same period last year. The company faced exceptional losses of ₹12.86 crore on a consolidated basis, primarily due to impairment provisions and adjustments related to new labor codes. Despite these one-off items, the operational growth remains robust, driven by both sales and service income.
Key Highlights
Consolidated revenue increased 28.3% YoY to ₹409.73 crore from ₹319.30 crore.
Consolidated Net Profit grew by 40.3% YoY reaching ₹44.58 crore.
Consolidated EPS improved to ₹2.36 from ₹1.63 in the previous year's corresponding quarter.
Standalone revenue grew 32% YoY to ₹165.70 crore with standalone PAT nearly doubling to ₹15.93 crore.
Exceptional items included a ₹2.58 crore charge for gratuity liability due to the implementation of New Labour Codes.
💼 Action for Investors
Investors should view the strong top-line and bottom-line growth positively, though the recurring nature of impairment provisions in subsidiaries warrants monitoring. The stock remains a 'Hold' with a focus on the scaling of the consolidated business.
Shilpa Medicare Q3 FY26 Consolidated PAT Up 40% YoY to ₹44.58 Cr; Revenue Grows 28%
Shilpa Medicare reported a robust performance for Q3 FY26, with consolidated revenue from operations growing 28.3% YoY to ₹409.73 crore. Net profit for the quarter increased by 40.3% YoY to ₹44.58 crore, despite an exceptional loss of ₹12.86 crore. For the nine-month period ending December 2025, the company's consolidated PAT more than doubled to ₹135.53 crore from ₹63.78 crore in the previous year. The board also inducted Mr. Ashraf Allam into the Audit Committee as an Independent Director.
Key Highlights
Consolidated revenue from operations rose 28.3% YoY to ₹409.73 crore in Q3 FY26.
Consolidated Net Profit (PAT) grew 40.3% YoY to ₹44.58 crore from ₹31.78 crore.
Nine-month consolidated PAT for FY26 reached ₹135.53 crore, a significant jump from ₹63.78 crore in FY25.
Exceptional items included a ₹2.58 crore charge related to the mandatory adoption of New Labour Codes.
Basic EPS for the quarter improved to ₹2.36 compared to ₹1.63 in the same quarter last year.
💼 Action for Investors
The strong YoY growth in both revenue and profitability indicates improving operational efficiency and scale. Investors should maintain a positive outlook while monitoring the impact of subsidiary impairments and labor code adjustments on future margins.
Shilchar Technologies Q3 Net Profit Rises 21.7% YoY to ₹42.34 Cr; Revenue Up 56%
Shilchar Technologies reported a robust year-on-year performance for Q3 FY26, with revenue from operations surging 56% to ₹156.46 crore compared to ₹100.25 crore in the previous year. Net profit for the quarter grew 21.7% YoY to ₹42.34 crore, although it saw a sequential decline of 7.8% from the September quarter. For the nine-month period ended December 2025, the company has delivered a strong net profit of ₹129.77 crore, up from ₹91.09 crore in the corresponding period last year. The company also successfully completed its listing on the National Stock Exchange (NSE) during this quarter.
Key Highlights
Revenue from operations grew 56% YoY to ₹156.46 crore in Q3 FY26.
Net profit increased 21.7% YoY to ₹42.34 crore, while 9M FY26 profit reached ₹129.77 crore.
Total income for the nine-month period ending Dec 2025 stood at ₹519.67 crore vs ₹316.94 crore YoY.
Earnings Per Share (EPS) for the quarter was ₹11.13, adjusted for the bonus issue in June 2025.
The company officially commenced trading on the NSE on November 24, 2025.
💼 Action for Investors
The company continues to show strong top-line growth in the transformer segment, making it a solid play in the power infrastructure space. Investors should monitor the slight sequential margin compression while remaining positive on the long-term growth trajectory and improved liquidity from the NSE listing.
Rushil Decor Q3 FY26: Revenue Up 2.3% to ₹216.5 Cr; Jumbo Laminate Phase 2 Commences
Rushil Decor reported a 2.3% YoY revenue growth to INR 2,165 million in Q3 FY26, though 9M FY26 revenue remains down 5.4% due to earlier operational disruptions. The company successfully commenced Phase 2 of its Jumbo Laminate facility, which contributed INR 6 crores this quarter and has a total revenue potential of INR 200 crores at 60% utilization. MDF margins faced pressure at 11.7% due to higher resin costs and competition, but domestic MDF revenue grew strongly by 29.4%. Management is pivoting towards value-added products, which now account for 54% of MDF revenue.
Key Highlights
Q3 FY26 Revenue grew 2.3% YoY to INR 2,165 million with an EBITDA margin of 10.7%
Domestic MDF revenue surged 29.4% YoY, while value-added products reached 54% of total MDF value
Laminate segment revenue increased 20.4% YoY to INR 585 million with a 9.8% EBITDA margin
Jumbo Laminate Phase 2 is now operational, targeting INR 200 crore revenue potential at 60% utilization
Net debt-to-equity remains comfortable at 0.41 as of December 2025
💼 Action for Investors
Investors should monitor the ramp-up of the Jumbo Laminate facility and the stabilization of resin prices, which are critical for margin recovery. The shift toward a 50% value-added MDF volume mix is a key metric to track for long-term profitability.
Hilton Metal Forging Approves ₹28 Crore Fundraise via Rights Issue
The Board of Directors of Hilton Metal Forging Limited has approved a proposal to raise capital up to ₹28 crores through the issuance of equity shares on a rights basis. The shares will have a face value of ₹10 each and will be offered to eligible shareholders as of a record date to be announced later. The company has also approved the Draft Letter of Offer and the appointment of intermediaries for the process. Specific details regarding the issue price and entitlement ratio are yet to be determined by the Board.
Key Highlights
Fundraising approved for an aggregate amount not exceeding ₹28,00,00,000 (₹28 Crores).
Issuance will be conducted via a Rights Issue to existing eligible shareholders.
Equity shares to be issued have a face value of ₹10 per share.
Board has approved the Draft Letter of Offer and appointment of various intermediaries.
Critical terms like issue price, rights ratio, and record date will be finalized in due course.
💼 Action for Investors
Investors should monitor future announcements regarding the rights entitlement ratio and issue price to evaluate the potential dilution and the attractiveness of the offer price compared to the market price.
Shilchar Technologies Proposes New Director Appointment and Remuneration Hikes
Shilchar Technologies has issued a postal ballot notice seeking shareholder approval for several key leadership and compensation changes. The company proposes appointing Mr. Aatman Alay Shah as a Whole-Time Director for a five-year term with a monthly remuneration of up to ₹14 lakhs. Additionally, the board seeks to increase the remuneration of existing Whole-Time Director Mr. Aashay Alay Shah to ₹14 lakhs per month starting April 2026. The notice also includes the appointment of Mr. Arvind Nopany as an Independent Director for five years.
Key Highlights
Proposed appointment of Mr. Aatman Alay Shah as Whole-Time Director for a 5-year term starting March 6, 2026.
Proposed monthly remuneration for Mr. Aatman Alay Shah capped at ₹14 lakhs plus perquisites.
Approval sought to increase Mr. Aashay Alay Shah's remuneration to ₹14 lakhs per month effective April 1, 2026.
Appointment of Mr. Arvind Nopany as Independent Director for a 5-year term until March 2031.
E-voting period for shareholders is scheduled from February 5, 2026, to March 6, 2026.
💼 Action for Investors
Investors should monitor if the proposed remuneration increases are commensurate with the company's profit growth and ensure that the leadership changes support long-term strategic goals.
Shilchar Tech Q3FY26: PAT Up 22% YoY, Revenue at ₹170 Cr with 30.8% EBITDA Margin
Shilchar Technologies reported a steady Q3FY26 with revenue growing 11% YoY to ₹170.26 crore and PAT increasing 22% to ₹42.34 crore. For the nine-month period (9MFY26), the company demonstrated stronger growth with PAT surging 42% to ₹129.77 crore. While domestic renewable demand remains robust, the company noted a temporary moderation in US export orders due to trade tariffs, which it aims to offset through Middle East expansion. The company remains debt-free and is progressing on a major capacity expansion to 14,000 MVA scheduled for April 2027.
Key Highlights
9MFY26 Revenue grew 28% YoY to ₹500.29 crore, while PAT surged 42% to ₹129.77 crore.
EBITDA margins improved to 30.8% in Q3FY26 from 28.3% in the same quarter last year.
Current production capacity of 7,500 MVA is expected to be fully utilized by the end of FY26.
Planned brownfield expansion to 14,000 MVA is on track for commissioning in April 2027.
Maintains a debt-free balance sheet with a projected order pipeline of ₹750-800 crore for FY26.
💼 Action for Investors
Investors should focus on the company's ability to maintain high margins despite export headwinds and monitor the execution of the 14,000 MVA capacity expansion. The debt-free status and strong domestic renewable tailwinds provide a solid cushion for long-term growth.
Shilchar Technologies Approves Q3 FY26 Unaudited Financial Results
Shilchar Technologies Limited has officially approved its unaudited financial results for the quarter and nine-month period ending December 31, 2025. The board meeting took place on January 31, 2026, and included the review of the statutory auditor's report. Although the specific profit and loss figures were not highlighted in the summary letter, the submission confirms compliance with SEBI listing regulations. Investors should now analyze the full financial statement to gauge the company's operational efficiency and growth in the transformer segment.
Key Highlights
Approval of unaudited financial results for the quarter ended December 31, 2025.
Approval of financial results for the nine-month period ended December 31, 2025.
Receipt of the Limited Review Report from the Statutory Auditors.
Board meeting concluded within one hour on January 31, 2026.
💼 Action for Investors
Review the detailed P&L and balance sheet figures in the full report to assess the company's growth trajectory. Compare the results against previous quarters to identify trends in the power and distribution transformer segment.
Rushil Decor Q3 Revenue up 2.3% to ₹2,165 Mn; PAT drops 54.7% on Margin Pressure
Rushil Decor reported a modest 2.3% YoY revenue growth in Q3 FY26, reaching ₹2,165 million, driven primarily by a strong 20.4% growth in the Laminates segment. However, profitability faced significant headwinds with EBITDA falling 15.4% to ₹231 million and PAT declining 54.7% to ₹52 million due to elevated resin prices and seasonal demand softness. The company is successfully transitioning towards value-added products, which now contribute 54% of MDF value. Notably, the balance sheet continues to strengthen with Net Debt to Equity improving to 0.41x from 1.10x in FY23.
Key Highlights
Q3 FY26 Revenue grew 2.3% YoY to ₹2,165 million, while PAT fell 54.7% to ₹52 million.
Laminates segment performed strongly with 20.4% YoY revenue growth and 52.1% EBITDA growth.
MDF segment saw domestic revenue growth of 29.4% YoY, though overall segment revenue dipped 3.5%.
Net Debt to Equity ratio significantly improved to 0.41x in 9M FY26 from 1.10x in FY23.
Phase 2 of Jumbo Laminates project commenced production in Q3 FY26, targeting high-margin export markets.
💼 Action for Investors
Investors should monitor the recovery in EBITDA margins as resin prices stabilize and the scale-up of the high-margin Jumbo Laminates segment. While short-term profitability is under pressure, the significant deleveraging and shift toward value-added products are positive long-term indicators.
Rushil Decor Q3 FY26 PAT Falls 54.7% YoY to ₹52 Mn; Laminates Revenue Up 20%
Rushil Decor reported a 2.3% YoY increase in Q3 FY26 revenue to ₹2,165 million, but PAT declined significantly by 54.7% to ₹52 million. Profitability was squeezed by elevated resin prices and forex losses, resulting in EBITDA margins contracting to 10.7% from 12.9% YoY. While the Laminates segment saw robust 20.4% revenue growth driven by domestic demand, the MDF segment faced a 3.5% revenue dip despite strong domestic volume growth of 31.3%. For the nine-month period, the company remains at a net loss of ₹37 million, primarily due to operational disruptions in Q1.
Key Highlights
Laminates segment revenue grew 20.4% YoY to ₹585 million with 93% capacity utilization.
Domestic MDF sales volume increased 31.3% YoY, though overall MDF revenue fell 3.5% to ₹1,486 million.
Value-added MDF products contributed 54% of the segment's total value during 9M FY26.
Consolidated EBITDA margin stood at 10.7%, impacted by high raw material costs and seasonal demand softness.
Net Debt to Shareholder Equity remains stable at a healthy 0.41x.
💼 Action for Investors
Investors should monitor the company's ability to pass on high resin costs and the progress of its high-margin jumbo laminate exports. While the YoY profit drop is significant, the strong domestic volume growth and shift toward value-added products provide a basis for long-term recovery.
Rushil Decor Q3 Standalone Net Profit Drops 50.7% YoY to ₹56.73 Million
Rushil Decor reported a weak performance for Q3 FY26, with standalone net profit falling 50.7% YoY to ₹56.73 million despite a marginal 2.3% increase in revenue to ₹2,152.25 million. For the nine-month period ended December 2025, the company reported a standalone net loss of ₹20.36 million, a sharp reversal from the ₹354.22 million profit in the same period last year. Profitability was severely impacted by declining margins in both the MDF and Laminates segments, alongside rising finance costs. The core MDF segment saw a revenue decline to ₹1,523.80 million compared to ₹1,556.75 million in the previous year's quarter.
Key Highlights
Standalone Q3 Net Profit plummeted 50.7% YoY to ₹56.73 million from ₹115.12 million.
Standalone Revenue for Q3 FY26 grew marginally by 2.3% YoY to ₹2,152.25 million.
MDF segment revenue declined to ₹1,523.80 million in Q3 FY26 from ₹1,556.75 million YoY.
Reported a standalone net loss of ₹20.36 million for the 9-month period ended Dec 2025 vs ₹354.22 million profit YoY.
Finance costs rose to ₹79.93 million in Q3 FY26 compared to ₹74.12 million in the corresponding quarter last year.
💼 Action for Investors
Investors should exercise caution as the company's profitability has significantly eroded, leading to a net loss on a nine-month basis. It is advisable to wait for signs of margin recovery in the MDF segment before considering fresh positions.
Shilpa Medicare Subsidiary Gets US FDA Orphan Drug Designation for Rare Blood Cancer Biologic
Shilpa Biologicals, a subsidiary of Shilpa Medicare, has achieved a major milestone with the US FDA granting Orphan Drug Designation (ODD) to its monoclonal antibody for treating rare blood cancers. The designation covers Essential Thrombocythemia (ET) and Polycythemia Vera (PV), conditions with high unmet medical needs. This regulatory status provides the company with development support, tax credits, and potential market exclusivity upon final approval. The company is now progressing toward IND-enabling studies to initiate first-in-human clinical trials.
Key Highlights
US FDA grants Orphan Drug Designation for a flagship biologic targeting ET and PV rare blood cancers.
Designation provides commercial incentives including tax credits and potential 7-year market exclusivity.
The biologic targets immune-evasion pathways, offering a differentiated profile from existing JAK inhibitors.
Shilpa Biologicals and mAbTree Biologics to advance the program to IND-enabling studies and human trials.
Milestone validates Shilpa Medicare's R&D capabilities in the high-value biologics and critical care space.
💼 Action for Investors
Investors should view this as a positive long-term development that strengthens the company's specialized R&D pipeline. Monitor future updates regarding IND filings and clinical trial progress as these will be the next major valuation catalysts.
HILINFRA Commences Toll Operations at Kaza Plaza; Order Book Reaches ₹1,209 Cr
Highway Infrastructure Limited (HIL) has commenced toll operations at the Kaza Fee Plaza on NH-16, marking its largest-ever single toll mandate valued at ₹328.77 crore. The Kaza Plaza is a high-traffic corridor and is recognized as the highest-earning public-funded toll plaza in South India, generating approximately ₹27 crore in monthly collections. This commencement has significantly boosted the company's total order book to ₹1,209 crore, with the tollways segment growing by 404% since March 2025. The project follows an asset-light model, ensuring immediate revenue generation and improved cash flow visibility for the next year.
Key Highlights
Commenced ₹328.77 crore toll operations contract at Kaza Fee Plaza, the largest in company history.
Total consolidated order book strengthened to ₹1,209 crore as of January 2026.
Tollways collection order book grew by ~404% from ₹114 crore in March 2025 to ₹575 crore.
EPC order book increased by 52% during the same period, reaching ₹633 crore.
Kaza Plaza generates the highest monthly toll in South India at approximately ₹27 crore.
💼 Action for Investors
Investors should monitor the company's execution efficiency and the impact of this high-value contract on upcoming quarterly earnings. The significant 404% growth in the tolling order book suggests a strong shift toward high-cash-flow operational revenue.